IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q4 2017 Holdings

Filed 2018-02-14 | 5 holdings | $394.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Denali Therapeutics Inc(DNLI)COM24823R105$139.5K8,918,74935.4%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$128.6K12,682,87632.6%
Editas Medicine Inc(EDIT)COM28106W103$51.5K1,674,43513.0%
Quanterix Corp(QTRX)COM74766Q101$43.6K2,030,49511.1%
Syros Pharmaceuticals IncCOM87184Q107$31.2K3,204,4377.9%